Less expensive anti-clotting medication appears as safe and effective as more expensive treatment

Subcutaneous (beneath the skin) injection of the original and less expensive form of the anticoagulant medication heparin is as effective and safe as subcutaneous administration of the newer and more expensive low-molecular-weight heparin for treatment of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs), according to a study in the August 23-30 issue of JAMA.

Heparin is used to treat thromboembolism, formation of a blood clot in a blood vessel. When unfractionated (regular) heparin is used in the treatment, it is usually administered intravenously with coagulation monitoring, which requires hospitalization. The standard approach includes ongoing dose adjustment in response to measurements of the APTT, a test that measures how well and fast the blood clots, and is used to determine the most effective dosage, according to background information in the article. Low-molecular-weight heparin administered by subcutaneous (under the skin) injection in fixed weight-adjusted doses is gradually replacing unfractionated heparin, according to background information in the article.

Clive Kearon, M.B., Ph.D., of McMaster University and the Henderson Research Centre, Hamilton, Ontario, and colleagues conducted a randomized trial to determine if fixed-dose subcutaneous unfractionated heparin is as effective and safe as low-molecular-weight heparin for treatment of venous thromboembolism. The study was conducted from September 1998 through February 2004 at six university-affiliated clinical centers in Canada and New Zealand. About 70 percent of both groups were treated as outpatients. All patients received three months of warfarin (an anticoagulant drug) therapy. Patients received either unfractionated or low-molecular-weight heparin administered subcutaneously.

Recurrent thromboembolism occurred in 3.8 percent of 345 patients in the unfractionated heparin group and in 3.4 percent of 352 patients in the low-mole

Contact: Veronica McGuire
JAMA and Archives Journals

Page: 1 2

Related medicine news :

1. PhD researcher develops inexpensive, sustainable production method in just 2 years
2. Inexpensive test detects H5N1 infections quickly and accurately
3. Virtual colonoscopy considerably more expensive
4. Is expensive new heart rhythm treatment worth it?
5. New, expensive, widely-used drugs continue to cause liver problems, says Jefferson liver specialist
6. Should doctors tell patients about expensive, unfunded drugs?
7. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
8. Stroke risk should determine anti-clotting treatment
9. Misdosing common for powerful anti-clotting drugs
10. Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study
11. Heart failure medication does not improve survival, compared to more widely used medication

Post Your Comments:

(Date:9/1/2020)... ... September 01, 2020 , ... ... fellowship training in aesthetic surgery of the face, breast, and body. In 2018, ... female-owned premier boutique plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... 1,400 N95 face masks to medical first responders across the United States. Since ... donations of personal protective equipment (PPE) medical centers , hospitals , ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... business support services to dental groups in the United States, today announced the ... community of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable ...
(Date:8/31/2020)... PASADENA, Calif. (PRWEB) , ... August 31, 2020 ... ... and leadership experience working, both directly with persons with autism and other developmental ... clinical expertise includes early intervention, parent education, adolescents with autism, school consultation, and ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... system designed to help treat patients with respiratory conditions, including COVID-19, while reducing ... helium and oxygen, but it captures exhaled gas and scrubs it free of ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... ... The GHT Companies , a leading developer and distributor of nutraceutical products, ... with a press conference at its manufacturing facility in Vista. Here are the ... overall donation result exceeding $30,000 to Feeding San Diego, Who: Jim Rex, CEO, ...
(Date:8/26/2020)... , ... August 26, 2020 ... ... of Eurofins BioPharma Services, Laboratory Testing division, expands its technology footprint with ... of Flow Cytometry platforms available. With industry-leading biomarker solutions, complemented with traditional ...
(Date:8/26/2020)... ... ... As the U.S. struggles in its 6th month of fighting Covid-19, Americans are ... keep your distance, wash your hands. Prevention is the best tool for now. Noted ... much better it is to prevent disease than to cure it.” , Part of ...
Breaking Medicine Technology:
Cached News: